Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Arterial tortuosity syndrome (ATS) is a rare connective tissue disorder characterized by tortuosity and elongation of the large and medium-sized arteries and a propensity towards aneurysm formation, vascular dissection, and stenosis of the pulmonary arteries.
Features include always present findings: Generalized arterial tortuosity; and very common findings: Aortic root aneurysm, Aortic tortuosity, Congestive heart failure, and Vascular dilatation and others. 88 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Heart and blood vessels | 15 | Aortic valve stenosis, Ischemic stroke, Aortic root aneurysm |
SLC2A10 function has not been fully characterized.
Arterial tortuosity syndrome is caused by mutations in the SLC2A10 gene on chromosome 20.
No formal diagnostic criteria have been established for arterial tortuosity syndrome (ATS).
Arterial tortuosity syndrome should be suspected in individuals with severe and widespread elongation and tortuosity of the aorta and mid-sized arteries along with the following additional possible findings:
Source: GeneReviews — "Arterial Tortuosity Syndrome"
No approved treatments are currently available for arterial tortuosity syndrome. The disease remains an area of unmet medical need.
No clinical practice guidelines for arterial tortuosity syndrome (ATS) have been published.
To establish the extent of disease and needs in an individual diagnosed with ATS, the evaluations summarized (if not performed as part of the evaluation that led to the diagnosis) are recommended.
Table 6. Recommended Surveillance for Individuals with Arterial Tortuosity Syndrome
System/Concern |
|---|
1 clinical trial registered. Interventions under study include other interventions. Research is primarily sponsored by academic and government institutions.
80 publications have been identified in PubMed for arterial tortuosity syndrome. Research spans Case Report / Case Series (30%), Epidemiology / Natural History (25%), and Basic Science / Preclinical (18%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 24 | 30% |
Data assembled from 9 of 12 sources · Last updated Sep 19, 2026, 2:54 PM UTC
Online Mendelian Inheritance in Man
European rare disease database
Genetic and Rare Diseases Info Center
Skin |
7 |
Thin skin, Telangiectases of the cheeks, Soft skin |
Head and neck | 6 | Progeroid facial appearance, High palate, Long face |
Brain and nerves | 5 | Ischemic stroke, Intellectual disability, Fatigue |
Bones and joints | 5 | Joint hypermobility, Sideways curvature of the spine (scoliosis), Abnormal zygomatic bone morphology |
Lungs and breathing | 4 | Pulmonary artery stenosis, Dyspnea, Respiratory distress |
Muscles | 3 | Flexion contracture, Low muscle tone (hypotonia), Generalized hypotonia |
Eyes | 2 | Keratoconus, Strabismus |
Arms and legs | 2 | Rocker bottom foot, Clinodactyly of the 5th finger |
Digestive system | 2 | Gastroesophageal reflux, Esophagitis |
Pregnancy and birth | 1 | Congenital diaphragmatic hernia |
Arterial tortuosity syndrome (ATS) is characterized by widespread elongation and tortuosity of the aorta and mid-sized arteries as well as focal stenosis of segments of the pulmonary arteries and/or aorta combined with findings of a generalized connective tissue disorder. ATS is a highly variable disorder ranging from early mortality during infancy to limited manifestations in adulthood [, , , ]. Most affected individuals are identified in early childhood, often because of a cardiac murmur or cyanosis. Subsequently manifestations of a generalized connective tissue disorder are often observed, prompting an echocardiogram that reveals aortic abnormalities with or without pulmonary artery stenosis. • About 12% of all affected individuals are admitted to the neonatal intensive care unit because of a primary presentation with infant respiratory distress syndrome. Underlying causes may be diverse and include insufficient lung maturation, pulmonary hypertension, and/or diaphragmatic hernia. • Few reports mention cardiorespiratory failure as the initial presentation during infancy or young childhood. • Cutaneous (cutis laxa, stretchable skin) and gastrointestinal (pyloric stenosis, failure to thrive) manifestations have been infrequently reported as the initial presenting symptoms. • Rare patients have been identified initially in adulthood, with joint aches and premature aging as the main presenting features . To date, 106 individuals with ATS and biallelic pathogenic variants in SLC2A10 have been identified [, , , ]. The following description of the phenotypic features associated with this condition is based on these reports. Table 2. Arterial Tortuosity Syndrome (ATS): Frequency of Select Features
Feature | % of Personsw/Feature1 | Comment |
|---|---|---|
Cardiovascular findings | Aortic tortuosity | 92% |
Tortuosity of other arteries | 80% | — |
Aortic root aneurysm | 16% | Aggressive in young childhood or slowly progressive in adolescence/adulthood |
Pulmonary artery stenosis | 57% | — |
Aortic stenosis | 24% | — |
Other arterial stenosis | 15% | — |
Autonomic dysfunction | 18% | — |
Craniofacial features | Characteristic facial features | ~60% |
Long face | 73% | — |
Downslanted palpebral fissures | 42% | — |
Convex nasal ridge | 37% | — |
Full cheeks | 54% | — |
Micrognathia | 58% | — |
High palate | 49% | — |
Cleft palate / bifid uvula | 7% | Findings of generalized connective |
tissue disorder | Joint hypermobility | 76% |
Joint pain | 26% | Progressive w/age |
Cutis laxa | 31% | — |
Inguinal hernia | 38% | — |
Diaphragmatic/sliding hernia | 29% | Skeletal |
findings | Pectus deformity | 28% |
Arachnodactyly | 30% | — |
Scoliosis | 22% | — |
Eye findings | Keratoconus | 15% |
Myopia | 43% | — |
Other | Respiratory tract | 15% |
Urogenital anomalies | 20% | 1. Cardiovascular involvement. The cardiovascular system is the major source of morbidity and mortality. Cardiovascular manifestations include congenital widespread tortuosity of the large and mid-sized arteries. |
Source: GeneReviews — "Arterial Tortuosity Syndrome"
summarizes disorders that should be considered in the differential diagnosis of arterial tortuosity syndrome (ATS).
Table 3.
Genes of Interest in the Differential Diagnosis of Arterial Tortuosity Syndrome
Gene(s) | DiffDx Disorder | MOI | Clinical Features of DiffDx Disorder | Distinguishing Clinical Features
ACTA2(BGN)COL3A1FBN1(FOXE3)(HCN4)LOX(MAT2A)(MFAP5)MYH11MYLKPRKG1SMAD3TGFB2(TGFB3)TGFBR1TGFBR21 | Heritable thoracic aortic disease (HTAD; familial thoracic aortic aneurysms)1 | AD | Aortic root dilatation may be isolated or assoc w/other vascular nonvascular features, incl marfanoid skeletal features as seen in ATS.1 | Though some of these thoracic aortic aneurysm syndromes may present w/mild tortuosity, severe tortuosity is usually absent, stenosis is rare (except in ACTA2-HTAD).
...
Source: GeneReviews — "Arterial Tortuosity Syndrome"
Genetic testing for SLC2A10 is available. Testing is considered confirmatory for diagnosis.
Biomarker and diagnostic research for arterial tortuosity syndrome has been reported in the published literature.
Recommended Evaluations Following Initial Diagnosis in Individuals with Arterial Tortuosity Syndrome
System/Concern | Evaluation | Comment
| Echocardiography | Aortic root measurements must be interpreted based on consideration of normal values for age body size.
| MRA or CT scan w/3D reconstruction from head to pelvis | To evaluate AT, identify abnormal implantation of aortic branches identify arterial aneurysms /or stenosis throughout arterial tree.
| Blood pressure measurements |
| Tilt testing | Only if history is suggestive
| Eval for cleft palate or bifid uvula |
Diaphragmatic hernia /
| Thoracoabdominal radiography |
| Clinical eval, skeletal radiographs |
| Bone densitometry | If diagnosed in adulthood
| Eval for keratoconus, keratoglobus corneal thinning, refractive errors |
| Ultrasound of urinary tract |
| By genetics professionals1 | To obtain a pedigree inform affected persons their families re nature, MOI, implications of ATS to facilitate medical personal deci...
Source: GeneReviews — "Arterial Tortuosity Syndrome"
Avoid the following:
Contact sports, competitive sports, and isometric exercise
Scuba diving because of pressure differences and the need for positive pressure ventilation
Agents that stimulate the cardiovascular system, including routine use of decongestants
Use of tobacco, which increases cardiovascular and pulmonary risk and the likelihood of premature skin aging
Sun tanning, which increases the likelihood of premature skin aging
Source: GeneReviews — "Arterial Tortuosity Syndrome"
Search ClinicalTrials.gov in the US and EU Clinical Trials Register in Europe for access to information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.
Source: GeneReviews — "Arterial Tortuosity Syndrome"
1 trial found
Evaluation
Frequency |
|---|
aortic root | Echocardiography | Every 3 mos until age 5 yrs; Annually thereafter if diameters of aorta are w/in normal limits; Under stable conditions (in absence of aneurysms, stenosis, or dilatation of aortic root), perform every 3 yrs in older children adults. Pulmonary |
hypertension | Echocardiogram | Per cardiologist Systemic |
hypertension | Blood pressure measurement | At each visit Dental |
crowding | Orthodontic eval | During eruption of permanent dentition |
Scoliosis | Radiographs to evaluate for progression of scoliosis | During periods of rapid growth (first 2 yrs of life during puberty) |
Ocular issues | Routine follow up for refractive errors keratoconus w/ophthalmologist w/expertise in connective tissue disorders | — |
Emphysema | Eval w/pulmonologist | Baseline lung function at age 18 yrs; Repeat exam based on symptomatology |
Source: GeneReviews — "Arterial Tortuosity Syndrome"
Phenotype severity distribution: 1 always present feature, 8 very common features, 24 common features.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
Disease patterns and progression |
20 |
25% |
Laboratory research | 14 | 18% |
Testing and diagnosis research | 8 | 10% |
Research summaries | 8 | 10% |
Clinical study results | 6 | 8% |
Roy A (2026). [PMID: 42146660](https://pubmed.ncbi.nlm.nih.gov/42146660/). *bioRxiv*. [Basic Science / Preclinical]
Ustunisik CT (2026). [PMID: 42183142](https://pubmed.ncbi.nlm.nih.gov/42183142/). *J Vasc Bras*. [Case Report / Case Series]
Spinella G (2026). [PMID: 39108028](https://pubmed.ncbi.nlm.nih.gov/39108028/). *J Endovasc Ther*. [Clinical Trial Publication]
Piepenburg SM (2026). [PMID: 42000294](https://pubmed.ncbi.nlm.nih.gov/42000294/). *Cardiovasc Revasc Med*. [Clinical Trial Publication]
Almabyouq FJ (2026). [PMID: 41743220](https://pubmed.ncbi.nlm.nih.gov/41743220/). *Front Pediatr*. [Case Report / Case Series]
Lee JV (2026). [PMID: 42184884](https://pubmed.ncbi.nlm.nih.gov/42184884/). *World Neurosurg*. [Epidemiology / Natural History]
Chida R (2026). [PMID: 41629640](https://pubmed.ncbi.nlm.nih.gov/41629640/). *J Hum Genet*. [Basic Science / Preclinical]
MacCarrick G (2026). [PMID: 41988792](https://pubmed.ncbi.nlm.nih.gov/41988792/). *Genet Med*. [Review / Meta-Analysis]
Uesugi S (2026). [PMID: 41789428](https://pubmed.ncbi.nlm.nih.gov/41789428/). *Ann Vasc Dis*. [Case Report / Case Series]
Lan Q (2026). [PMID: 42173185](https://pubmed.ncbi.nlm.nih.gov/42173185/). *Am J Obstet Gynecol*. [Diagnostic / Biomarker]